Target Name: MIR616
NCBI ID: G693201
Review Report on MIR616 Target / Biomarker Content of Review Report on MIR616 Target / Biomarker
MIR616
Other Name(s): hsa-miR-616-5p | microRNA 616 | hsa-mir-616 | hsa-miR-616-3p | MicroRNA 616 | MIRN616

MIR616: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker

MIR616 (hsa-miR-616-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and various studies have shown that MIR616 can be effectively targeted to the endoplasmic reticulum (ER) and can interact with various drug molecules, suggesting that it may have a promising role in drug development.

MIR616 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and can interact with various target genes to regulate their expression levels. One of the well-known functions of miRNAs is to target mRNAs for degradation, translation, or cleavage, and MIR616 is no exception. It has been shown to interact with various target genes, including coding and non-coding RNAs, and can regulate their expression levels.

One of the unique features of MIR616 is its expression pattern. It is mainly expressed in the brain and nervous system, and its levels are significantly higher in these tissues compared to other tissues. It has also been shown to be involved in the regulation of neural development and plasticity, making it an attractive target for researchers studying the role of miRNAs in brain function.

In addition to its expression pattern, MIR616 has also been shown to interact with various drug molecules. It has been shown to interact with small molecules, such as drugs that are currently being developed for various diseases, including cancer. One of the most promising aspects of MIR616 is its potential as a drug target, as it can interact with a variety of small molecules and may be a useful indicator of disease status or treatment response.

MIR616 has also been shown to play a role in the regulation of cellular processes that are important for cancer progression. It has been shown to be involved in the regulation of cell cycle progression, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). These processes are important for cancer growth and progression, and targeting MIR616 may be a promising strategy for cancer treatment.

In conclusion, MIR616 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases. Its unique expression pattern and interaction with various drug molecules make it an attractive target for researchers to study. Further studies are needed to fully understand the role of MIR616 in disease progression and the potential of targeting it for cancer treatment.

Protein Name: MicroRNA 616

The "MIR616 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR616 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626 | MIR627 | MIR628 | MIR629 | MIR630 | MIR631 | MIR632 | MIR633 | MIR634 | MIR635 | MIR636 | MIR637 | MIR638 | MIR639 | MIR640 | MIR641 | MIR642A | MIR642B | MIR643 | MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734